How deeply rooted are the molecular drivers of aging, and what does their conservation across plants and animals reveal about longevity itself? Building on Horvath’s landmark epigenetic clock findings (Nature, August 2023), this comparative genomic study probes 49 pivotal genes in mammals, fish, reptiles, birds, insects, plants, bacteria, and archaea. Strikingly, only four of these genes—LARP1, SNX1, HDAC2, and PRC2—emerge as universal eukaryotic anchors, linking epigenetic and developmental processes from leaves to limbs. Beyond these plant-present regulators, additional tiers of conservation appear in insects—yet vanish in simpler prokaryotes—revealing a layered evolutionary tapestry of increasing regulatory sophistication. This cross-kingdom perspective offers potent insights for aging researchers and evolutionary biologists alike, suggesting that the very architecture of longevity is inscribed into genes that first took shape at life’s eukaryotic dawn.
Abstract
Recent anecdotal evidence and clinical observations suggest that high-dose vitamin D3 (cholecalciferol) supplementation may have an underappreciated anti-cancer effect. Concurrently, the metabolic theory of cancer, espoused by Thomas Seyfried and others, highlights the importance of mitochondrial bioenergetics and the Warburg effect in oncogenesis. This article synthesizes these perspectives, proposing that high-dose vitamin D3 can enhance mitochondrial function and provide the energetic “push” needed to carry out proper apoptosis—a process that can stall under conditions of metabolic insufficiency. We further explore how classic oncogenic mutations (e.g., TP53, RB1, PTEN, BCL-2 family genes) compromise apoptosis in ways that are exacerbated by impaired mitochondrial energy output. Drawing from case reports, mechanistic studies on vitamin D3 and histone deacetylases (particularly HDAC2), and the evolutionary logic that cancer may be a reversion to a more primordial cell state, we present a compelling case for high-dose vitamin D3 as an adjunctive or primary therapy that targets the metabolic underpinnings of malignancies.
This multimodal model reveals Alzheimer’s disease not as a single pathological process, but as the inevitable consequence of evolutionarily-programmed aging systems that co-opt each other’s vulnerabilities 145. The evidence suggests that:
Aging is programmed: The precise coordination of these declining systems suggests evolutionary selection for aging rather than random deterioration 128
RNA-level intervention is key: Since the damage occurs at the mRNA splicing level rather than DNA, aging remains potentially reversible 12526
Early intervention is critical: The cascade accelerates once multiple systems are compromised, making prevention far more effective than late-stage treatment 45
Combination therapy is essential: No single intervention can address the interconnected nature of this multi-system failure 145
This paradigm shift from viewing Alzheimer’s as an isolated brain disease to understanding it as the culmination of coordinated aging systems opens new therapeutic possibilities and explains why previous single-target approaches have largely failed. The future of Alzheimer’s treatment lies in addressing this complex, interconnected cascade at multiple levels simultaneously.
HYPOTHESIS: SP1 AND MAO-B AS MISSING PIECES IN HORVATH’S FRAMEWORK
Horvath’s universal mammalian clock identifies ~35-48 genes (e.g., LHFPL4, ZIC family) near CpGs gaining methylation with age, enriched in developmental TFs and PRC2 sites. Bowles highlights SP1 from Horvath’s data as regulating MAO-A/B, yet Horvath’s list excludes such integrators, focusing on autosomal loci to emphasize conserved drift over programmed intent. This narrowing might avoid “rocking the boat”: admitting programmed aging (e.g., MAO-B as evolved for species-level benefits like genetic diversity against predators) contradicts selfish gene theory, where deleterious traits shouldn’t persist without early advantages.
Creatively, envision aging as evolution’s “diversity engine”: MAO-B, upregulated by SP1 post-puberty, depletes FAD symmetrically to CD38’s NAD+ hit, crippling 80% of ETC protons and enforcing senescence. In asexual/non-aging species (e.g., planaria), uniformity leads to extinction via evolving threats; sexual/aging species (via switches like MAO-B) foster variation, migrating to fill niches. KS’s extra X disrupts this switch—extra MAO copies, modulated by escapees or hormones, “jam” the program, slowing clocks. Horvath’s list, by omitting SP1/MAO regulators, sidesteps this, portraying aging as stochastic byproduct rather than adaptive code.
This report examines the hypothesis that the convergence of increased childhood aluminum exposure through expanded vaccination schedules, rising magnesium deficiency, and declining vitamin D3 synthesis due to reduced sun exposure has created optimal conditions for the dramatic rise in autism spectrum disorder (ASD) diagnoses since the 1980s. Drawing from insights gained in amyotrophic lateral sclerosis (ALS) research showing that elevated aluminum-to-magnesium ratios contribute to neurodegeneration, we propose a similar mechanism may operate in autism pathogenesis. This analysis synthesizes epidemiological data on vaccine schedules, aluminum exposure patterns, outdoor activity trends, and autism prevalence to evaluate this multi-factorial hypothesis.
I had AI do a quick summary of a very comprehensive deep dive study of Horvath’s 48 aging related genes from the first preprint of his seminal paper Universal DNA methylation age across mammalian tissues -Nature Aging August 2023- The deep dive will be available in my upcoming book on the subject
here’s what it gave us:
What follows is an overview of Stephen Horvath’s Universal Mammalian Epigenetic Aging system. This updated review:
Clarifies that Thymine DNA Glycosylase (TDG), not TET enzymes, is the primary mechanism preventing hypermethylation of these aging-related genes (TDG is α-ketoglutarate dependent).
Explains that the initial 48 genes come from Horvath’s first preprint, and subsequent revisions have added or changed several genes (including transcription factor SP1).
Highlights how SP1 ties together MAO-A/MAO-B, FAD sequestration, WRN protein expression, and a potential impact on aging processes.
Presents a CD38/NAD+ analysis of the 48 genes, discussing how some of them may influence CD38 activity, thereby modulating NAD+ levels.
Throughout, we underscore the interplay of GABA–α-KG–glutamate, the overrepresentation of splicing-related genes, and the newly emphasized roles of SP1 and MAO in driving epigenetic and metabolic shifts that contribute to aging.